MarketPeel
President and CEO
Wed, May 7, 2025
May 7
exercised or converted securities in CRVS
559,073 shares @ $0.00
Decreased holdings by -100.00%
Net across this filing: +96.80% (+559,073 shares)
Win rate excludes trades classified as routine (tax, 10b5-1, exercise, gift).
CRVSCorvus Pharmaceuticals, Inc.
HealthcareBiotechnology
1D0.00%
1W-4.99%
1M+7.80%
3M+8.97%
6M
1Y

Recent insider activity at CRVS

FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback